
Health tech informatics firm Aridhia has appointed Chris Roche to a newly-created post on its executive team as chief commercial …

The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …

A new fund has raised more than £47.5 million to help set up early-stage life science and health technology companies …

Samsung has taken another step towards realising the potential of wearable health tech with the launch of a new ‘smart’ …

Boehringer Ingelheim has sought to bring to an end around 4,000 legal cases which have been brought against the company …

Japan-based pharma firm Taiho Oncology has appointed Tim Whitten to the position of senior vice president and chief commercial officer. …

The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

Doctors are warning that patients and members of their own profession are increasingly turning to Wikipedia for medical information, but …
Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …

UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

 George has over 20 …

Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …

When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …

Amersham-based UK medical education company Wave has appointed three new members of staff. Charlotte Wilkinson joins as programme manager and …

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …
Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …

Creative agency PAN has reinforced its account handling and planning teams with two new arrivals and three promotions. Aisha Regan …